Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 271.83 USD 0.54% Market Closed
Market Cap: 19.1B USD
Have any thoughts about
Insulet Corp?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Insulet Corp

Revenue
2B USD
Cost of Revenue
-607.9m USD
Gross Profit
1.4B USD
Operating Expenses
-1.1B USD
Operating Income
306m USD
Other Expenses
114.9m USD
Net Income
420.9m USD

Margins Comparison
Insulet Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Insulet Corp
NASDAQ:PODD
19.1B USD
69%
15%
21%
US
Abbott Laboratories
NYSE:ABT
194.8B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
195B USD
67%
26%
29%
US
Boston Scientific Corp
NYSE:BSX
139.8B USD
69%
18%
11%
US
Stryker Corp
NYSE:SYK
139.4B USD
64%
22%
16%
IE
Medtronic PLC
NYSE:MDT
103.5B USD
65%
19%
13%
US
Becton Dickinson and Co
NYSE:BDX
67.5B USD
45%
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
57.6B EUR
38%
13%
9%
US
Edwards Lifesciences Corp
NYSE:EW
43.3B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.7B USD
41%
13%
9%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
280.1B CNY
64%
36%
33%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Insulet Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Insulet Corp
NASDAQ:PODD
19.1B USD
49%
15%
13%
22%
US
Abbott Laboratories
NYSE:ABT
194.8B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
195B USD
16%
14%
14%
19%
US
Boston Scientific Corp
NYSE:BSX
139.8B USD
9%
5%
9%
7%
US
Stryker Corp
NYSE:SYK
139.4B USD
19%
9%
14%
11%
IE
Medtronic PLC
NYSE:MDT
103.5B USD
9%
5%
8%
7%
US
Becton Dickinson and Co
NYSE:BDX
67.5B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
57.6B EUR
11%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
43.3B USD
51%
37%
16%
18%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.7B USD
22%
5%
10%
7%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
280.1B CNY
33%
22%
30%
37%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.